Logo for IRLAB Therapeutics

IRLAB Therapeutics Investor Relations Material

Latest events

Logo for IRLAB Therapeutics

Q4 2023

IRLAB Therapeutics
Logo for IRLAB Therapeutics

Q4 2023

7 Feb, 2024
Logo for IRLAB Therapeutics

Q3 2023

25 Oct, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from IRLAB Therapeutics

Access all reports
IRLAB Therapeutics AB is a research and development company developing drugs for the treatment of Parkinson's disease. IRLAB develops drugs that can stop or slow down the loss of neurons in the substantia nigra, where dopamine is produced. In Parkinson's disease, loss of these neurons leads to a gradual degeneration of the motor functions. These drugs will improve symptoms without dramatically increasing the risk of side effects.